Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Jessica C. Hochberg, MD, Stanton Goldman, MD, Matthew J. Barth, MD, Qiuhu Shi, PhD, Liana Klejmont, Pharm D, Lauren Harrison, RN, MSN, Jackie Basso, Yaya Chu, PhD, Humayun Islam, Perry Gerard, MD MBA, FACR, Javier Oesterheld, MD, Kenneth Matthew Heym, MD, Ivan I. Kirov, MD, Richard A. Drachtman, MD, Paul Harker-Murray, MD PhD, Sherrie L. Perkins, MD PhD, Rodney R. Miles, MD PhD, Bruce Shiramizu, MD, Mitchell S Cairo, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139464

Published: 2020

Journal Articles

Children's Oncology Group (COG) AALL0434: Successful Disease Control without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL)

Robert James Hayashi, Stuart S. Winter, MD, Kimberly P. Dunsmore, MD, Meenakshi Devidas, PhD, Brent Wood, MD PhD, Michelle L. Hermiston, MD PhD, David T Teachey, MD, Sherrie L. Perkins, MD PhD, Rodney R. Miles, MD PhD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Naomi Winick, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Megan S. Lim, MD,PhD, Catherine M. Bollard, MD, Thomas G. Gross, MD PhD

Blood (2018) 132 (Supplement 1): 1000.

https://doi.org/10.1182/blood-2018-99-113481

Published: 2018

Journal Articles

Ibrutinib Significantly Prolonged Survival in a Human Burkitt Lymphoma (BL) Xenograft NSG Mouse Model: Ibrutinib May be a Potential Adjuvant Agent in the Treatment of BL

Sanghoon Lee, PhD MSc., Changhong Yin, MD MS, Janet Ayello, MS, Erin Morris, RN, Timmy O'Connell, MS, Lauren Harrison, RN, MSN, Carmella van de Ven, MA, Matthew J. Barth, MD, Rodney R. Miles, MD PhD, Paul J. Galardy, MD, Stanton Goldman, MD, Megan S Lim, MD PhD, Michelle L. Hermiston, MD PhD, Linda McAllister-Lucas, MDPhD, Lisa Giulino-Roth, MD, Sherrie L. Perkins, MD PhD, Mitchell S. Cairo, MD

Blood (2015) 126 (23): 5117.

https://doi.org/10.1182/blood.V126.23.5117.5117

Published: 2015

Journal Articles

Ibrutinib Alone and in Combination with Dexamethasone and Carfilzomib Significantly Inhibits Cell Proliferation in Primary Mediastinal B-Cell Lymphoma (PMBL): Ibrutinib May be a Future Targeted Agent in Combination Therapy in Patients with PMBL

Sanghoon Lee, PhD MSc., Changhong Yin, MD MS, Janet Ayello, MS, Erin Morris, RN, Lauren Harrison, RN, MSN, Carmella van de Ven, MA, Matthew J. Barth, MD, Rodney R. Miles, MD PhD, Paul J. Galardy, MD, Stanton Goldman, MD, Megan S Lim, MD PhD, Michelle L. Hermiston, MD PhD, Linda McAllister-Lucas, MDPhD, Lisa Giulino-Roth, MD, Sherrie L. Perkins, MD PhD, Mitchell S. Cairo, MD

Blood (2015) 126 (23): 4852.

https://doi.org/10.1182/blood.V126.23.4852.4852

Published: 2015

Journal Articles

Next-Generation IgVH Sequencing of Monoclonal B-Cell Lymphocytosis Reveals Clonal Heterogeneity, Ongoing Mutation, and Repertoire Differences Relative to Chronic Lymphocytic Leukemia

Mark Klinger, Malek Faham, Jianbiao Zheng, PhD, Kojo S.J. Elenitoba-Johnson, MD, Sherrie L. Perkins, MD PhD, David W Bahler, MD PhD

Blood (2014) 124 (21): 1960.

https://doi.org/10.1182/blood.V124.21.1960.1960

Published: 2014

Journal Articles

The Clinical Utility Of Next-Generation Sequencing In The Diagnosis Of Polycythemia

Roberto H Nussenzveig, PhD, Mohamed E Salama, MD, Sherrie L. Perkins, MD, PhD, Josef Prchal, MD, Archana M Agarwal, MD

Blood (2013) 122 (21): 2185.

https://doi.org/10.1182/blood.V122.21.2185.2185

Published: 2013

Journal Articles

Hemopoietic Stem Cells In Polycythemia Vera and Essential Thrombocythemia Have Increased TNF-Alpha That Decreases After Pegylated Interferon-a Therapy, But Not Hydroxyurea, and Correlates With Suppression Of PV and ET Clones

Sabina Swierczek, PhD, Mohamed E Salama, MD, Katherine King, MD, PhD, Andrew Wilson, PhD, Sheryl Tripp, MD, Sherrie L. Perkins, MD, PhD, Margaret A. Goodell, PhD, Josef T. Prchal, MD

Blood (2013) 122 (21): 2827.

https://doi.org/10.1182/blood.V122.21.2827.2827

Published: 2013

Journal Articles

G6PD Deficient Variants Differ in Risk of Hospitalization Among Gaza Strip Palestinian Children

Noel S. Reading, PhD, Mahmoud M. Sirdah, PhD, Sherrie L. Perkins, MD, PhD, Andrew R. Wilson, MStat, Mohammad E. Shubair, PhD, Lina Aboud, MSc, Josef T. Prchal, MD

Blood (2012) 120 (21): 4268.

https://doi.org/10.1182/blood.V120.21.4268.4268

Published: 2012

Journal Articles

PTEN Expression Is Decreased in Pediatric Burkitt Lymphoma Tissues but Does Not Correlate with AKT Activation.

Rodic Vladimir, Tripp Sheryl, Michael G Bayerl, MD, Phillip Barnette, MD, Joshua D. Schiffman, MD, Sherrie L. Perkins, MD, PhD, Rodney R. Miles, MD, PhD

Blood (2012) 120 (21): 2664.

https://doi.org/10.1182/blood.V120.21.2664.2664

Published: 2012

Journal Articles

Genomic Pathways and Potential Therapeutic Targets in Pediatric Burkitt Lymphoma (PBL): A Children's Oncology Group Report

Mitchell S. Cairo, MD, Nancy Day, Ph.D., Stanton Goldman, MD, Warren G. Sanger, PhD, Lauren Harrison, RN, MSN, Megan S. Lim, MD, PhD, Rodney R. Miles, MD, PhD, Sherrie L. Perkins, MD, PhD

Blood (2011) 118 (21): 1587.

https://doi.org/10.1182/blood.V118.21.1587.1587

Published: 2011

Journal Articles

Single Center Experience with Screening for JAK2 V617F, cMPL W515L, cMPL W515K, and JAK2 L611V Mutations in MPN. Rarity of JAK2 L611V Does Not Justify Its Routine Screening

Soo Jin Kim, MST, Sabina Swierczek, PhD, Jonathan Schumacher, M.S., Todd W. Kelley, MD, Sherrie L. Perkins, MD, PhD, Josef T. Prchal, MD

Blood (2011) 118 (21): 5167.

https://doi.org/10.1182/blood.V118.21.5167.5167

Published: 2011

Journal Articles

The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM+ and CNS+ Mature B-NHL: A Children's Oncology Group Report

Stanton Goldman, MD, Paul J. Galardy, MD, Lynette Smith, MS, Sherrie L. Perkins, MD, PhD, Bruce Shiramizu, MD, Thomas Gross, MD, PhD, Warren G. Sanger, PhD, Lauren Harrison, RN, MSN, Mitchell S. Cairo, MD

Blood (2011) 118 (21): 2702.

https://doi.org/10.1182/blood.V118.21.2702.2702

Published: 2011

Journal Articles

Comparative Genomic Identification of Unique Signal Transduction Pathways and Targets In Pediatric Burkitt Lymphoma (PBL)

Nancy S Day, PhD, Janet Ayello, MS, MT(ASCP), Ian Waxman, MD, Carmella van de Ven, MA, Megan S. Lim, MD, PhD, Sherrie L. Perkins, MD, PhD, Warren G. Sanger, PhD, Lauren Harrison, RN, MSN, Stan Goldman, MD, Mitchell S. Cairo, MD

Blood (2010) 116 (21): 631.

https://doi.org/10.1182/blood.V116.21.631.631

Published: 2010

Journal Articles

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

Megan S. Lim, MD, PhD, Karen Pulford, PhD, FRCPath, Kamel Ait-Tahar, PhD, Suketu D. Patel, MSc, Marsha C. Kinney, MD, Sherrie L. Perkins, MD, PhD, James R. Anderson, PhD, Lynette Smith, MS, Mitchell S. Cairo, MD, Sheila Weitzman, MB, Thomas G. Gross, MD, PhD, Jacqueline M. Kraveka, DO

Blood (2010) 116 (21): 4130.

https://doi.org/10.1182/blood.V116.21.4130.4130

Published: 2010

Journal Articles

High Resolution Genome-Wide Copy Number Analysis of Pediatric Burkitt Lymphoma Identifies Copy Number Alterations In the Majority of Patients

Joshua D. Schiffman, MD, Patrick D. Lorimer, BS, Vladimir Rodic, BS, Mona S. Jahromi, BS, Jonathan M. Downie, BS, Michael G. Bayerl, MD, Sherrie L. Perkins, MD, PhD, Phillip Barnette, MD, Rodney R. Miles, MD, PhD

Blood (2010) 116 (21): 3123.

https://doi.org/10.1182/blood.V116.21.3123.3123

Published: 2010

Journal Articles

Preliminary Results of the Addition of Rasburicase to the Reduction Cycle and Rituximab to the Induction and Consolidation Cycles of FAB Group C Chemotherapy in Children and Adolescents with Advanced Stage (Bone Marrow ±CNS) Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children's Oncology Group Report.

Stanton Goldman, MD, James Lynch, PhD, Lauren Harrison, RN, Thomas Gross, MD, PhD, Bruce Shiramizu, MD, Warren Sanger, PhD, Sherrie L. Perkins, MD, PhD, Mitchell S. Cairo, MD

Blood (2009) 114 (22): 104.

https://doi.org/10.1182/blood.V114.22.104.104

Published: 2009

Journal Articles

DLEU1 siRNA Gene Knockdown IN BURKITT LYMPHOMA (bl) IS ASSOCIATED with A SIGNIFICANT Decrease IN Cyclophosphamide (CY) and/or Rituximab Induced Apoptosis: Mechanism of Drug Resistance in BL.

Nancy Day, Ph.D., Janet Ayello, MS, MT, Carmella van de Ven, MA, Megan S Lim, MD, PhD, Sherrie L. Perkins, MD, PhD, Warren Sanger, PhD, Lauren Harrison, RN, Stanton Goldman, MD, Mitchell S. Cairo, MD

Blood (2009) 114 (22): 1928.

https://doi.org/10.1182/blood.V114.22.1928.1928

Published: 2009

Journal Articles

Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL).

Karen E Deffenbacher, Ph.D., Javeed Iqbal, Ph.D., Zhongfeng Liu, M.D., Sherrie L. Perkins, MD, PhD, Megan S Lim, Kai Fu, MD, PhD, Yulei Shen, MD, PhD, Louis M. Staudt, MD, PhD, Lisa M. Rimsza, MD, Elaine S Jaffe, MD, Andreas Rosenwald, MD, German Ott, MD, Jan Delabie, MD, Elias Campo, MD, PhD, Randy D. Gascoyne, MD, Dennis D. Weisenburger, MD, Timothy C. Greiner, MS, MD, Thomas Gross, MD, PhD, Wing C. Chan

Blood (2009) 114 (22): 2922.

https://doi.org/10.1182/blood.V114.22.2922.2922

Published: 2009

Journal Articles

Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab + FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children’s Oncology Group Report

Mitchell S. Cairo, MD, James Lynch, PhD, Lauren Harrison, RN, Carmella van de Ven, MS, Thomas Gross, MD, PhD, Bruce Shiramizu, MD, Warren Sanger, PhD, Sherrie L. Perkins, MD, PhD, Stanton Goldman, MD

Blood (2008) 112 (11): 838.

https://doi.org/10.1182/blood.V112.11.838.838

Published: 2008

Journal Articles

Three Heritable T Cell Malignancy Models Established Using a Forward Genetic Mutagenesis Screen in Zebrafish.

J. Kimble Frazer, MD, PhD, Nathan Meeker, MD, Diana F. Bradley, Lynnie Rudner, Sherrie L. Perkins, MD, PhD, Nikolaus Trede, MD, PhD

Blood (2008) 112 (11): 2052.

https://doi.org/10.1182/blood.V112.11.2052.2052

Published: 2008

NARROW

Final Report of Reduced Anthracycline Dose Intensity with the Addition of Dose Dense Rituximab in Children, Adolescents and Young Adults with De Novo Good Risk Mature B-Cell Non Hodgkin Lymphoma (B-NHL)

Children's Oncology Group (COG) AALL0434: Successful Disease Control without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL)

Ibrutinib Significantly Prolonged Survival in a Human Burkitt Lymphoma (BL) Xenograft NSG Mouse Model: Ibrutinib May be a Potential Adjuvant Agent in the Treatment of BL

Ibrutinib Alone and in Combination with Dexamethasone and Carfilzomib Significantly Inhibits Cell Proliferation in Primary Mediastinal B-Cell Lymphoma (PMBL): Ibrutinib May be a Future Targeted Agent in Combination Therapy in Patients with PMBL

Next-Generation IgVH Sequencing of Monoclonal B-Cell Lymphocytosis Reveals Clonal Heterogeneity, Ongoing Mutation, and Repertoire Differences Relative to Chronic Lymphocytic Leukemia

The Clinical Utility Of Next-Generation Sequencing In The Diagnosis Of Polycythemia

Hemopoietic Stem Cells In Polycythemia Vera and Essential Thrombocythemia Have Increased TNF-Alpha That Decreases After Pegylated Interferon-a Therapy, But Not Hydroxyurea, and Correlates With Suppression Of PV and ET Clones

G6PD Deficient Variants Differ in Risk of Hospitalization Among Gaza Strip Palestinian Children

PTEN Expression Is Decreased in Pediatric Burkitt Lymphoma Tissues but Does Not Correlate with AKT Activation.

Genomic Pathways and Potential Therapeutic Targets in Pediatric Burkitt Lymphoma (PBL): A Children's Oncology Group Report

Single Center Experience with Screening for JAK2 V617F, cMPL W515L, cMPL W515K, and JAK2 L611V Mutations in MPN. Rarity of JAK2 L611V Does Not Justify Its Routine Screening

The Efficacy of Rasburicase and Rituximab Combined with FAB Chemotherapy in Children and Adolescents with Newly Diagnosed Stage III/IV, BM+ and CNS+ Mature B-NHL: A Children's Oncology Group Report

Comparative Genomic Identification of Unique Signal Transduction Pathways and Targets In Pediatric Burkitt Lymphoma (PBL)

The Autoantibody Response to ALK In Pediatric Anaplastic Large Cell Lymphoma: A Children's Oncology Group Report

High Resolution Genome-Wide Copy Number Analysis of Pediatric Burkitt Lymphoma Identifies Copy Number Alterations In the Majority of Patients

DLEU1 siRNA Gene Knockdown IN BURKITT LYMPHOMA (bl) IS ASSOCIATED with A SIGNIFICANT Decrease IN Cyclophosphamide (CY) and/or Rituximab Induced Apoptosis: Mechanism of Drug Resistance in BL.

Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL).

Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab + FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children’s Oncology Group Report

Three Heritable T Cell Malignancy Models Established Using a Forward Genetic Mutagenesis Screen in Zebrafish.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only